Skip to content

Cerebrolysin 60mg

♢ Research use only Spec på klassnivå; utvalda partier testade av Janoshik

Innehållsanalys Content quantification (Janoshik)Cerebrolysin 60mg · Report #212145 ↗

€28.99

Free standard EU shipping on orders over €200

If a product doesn't match the specification on its published COA, contact us with your batch number: we investigate against the lot's report and replace any product that fails it, at no cost to you.

Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.

Returns policy →
Shipping estimate for EU

3–7 days most of the EU · 10–14 Nordics/Baltics. Dispatched within 1–2 business days. Check destination rates at checkout.

Full shipping information

Cerebrolysin av forskningskvalitet. Registrerad specifikation: peptidhydrolysat (extrakt från svinhjärna), ≥85% peptider ≤10 kDa; utvalda partier oberoende testade. Lyofiliserat pulver i förseglad glasvial. Endast för forskningsändamål. Ej avsett för mänsklig konsumtion.

Om Cerebrolysin 60mg

Cerebrolysin is a multi-peptide brain-derived neurotrophic preparation consisting of enzymatically treated porcine brain protein. The preparation contains a mixture of low-molecular-weight neuropeptides and free amino acids that cross the blood-brain barrier. It has an unusually long history for a peptide complex and has been studied in the context of neurological injury models including ischemic, traumatic, and vascular insults — and has been characterised since the 1970s. Each vial contains 60mg of the lyophilized preparation.

The active components of Cerebrolysin are not fully defined chemically, which distinguishes it from single-compound neurotrophic peptides. The preparation has demonstrated neurotrophic factor-like activity in cell culture and animal models: it promotes neuronal survival, enhances synaptic plasticity, stimulates neurogenesis, and exhibits neuroprotective effects in various injury models. Preclinical and in-vitro studies have examined its effects on recovery and cognitive parameters in injury and neurodegeneration models, with variable results across study designs. The European Medicines Agency has characterised it within some neurological research contexts.

For research purposes, Cerebrolysin is a useful tool for studying multi-factor neurotrophic support — where the combined effect of multiple small peptides may recapitulate some of the biological activity of endogenous neurotrophic factors (BDNF, NGF, GDNF) more completely than any single defined compound.

Specifications

Parameter Value
Compound Cerebrolysin (porcine brain-derived neuropeptide complex)
Amount per Vial 60mg lyophilized
Composition Low-MW neuropeptides + free amino acids from porcine brain proteins
Format Lyophilized powder
Reconstitution Sterile water or saline
Förvaring 2-8°C

Förvaring

Store at 2-8°C (refrigerator) as lyophilized powder. Refrigerate after reconstitution. As a biological preparation, avoid freezing and thawing cycles.

What makes Cerebrolysin different from a single neurotrophic peptide?

Single neurotrophic peptides (like BDNF or NGF) target specific receptors. Cerebrolysin contains a mixture of multiple small peptides and amino acids that together mimic aspects of the brain’s complex neurotrophic environment. In research, this can be advantageous when the goal is broad neuroprotection or neurogenesis stimulation rather than receptor-specific pharmacology. The trade-off is that the mixture composition is not fully defined, which limits mechanistic interpretation. Cerebrolysin is better suited for studies where the preparation itself is the research focus, or for generating hypotheses that can then be pursued with defined single compounds.

How does Cerebrolysin penetrate the blood-brain barrier?

Cerebrolysin’s active components are specifically the low-molecular-weight fraction (peptides under approximately 10 kDa) — the preparation is enzymatically processed to ensure these small peptides predominate. Small peptides can cross the blood-brain barrier through passive diffusion (if sufficiently lipophilic), transcytosis, or active transport. The preparation is documented to produce measurable CNS effects after systemic IV or IM administration in preclinical models, indicating at least partial CNS delivery. The full pharmacokinetics of the mixed preparation are complex to characterize precisely.

What are the main research areas for Cerebrolysin?

The most-studied research area for Cerebrolysin is ischemic injury models — preclinical work has examined neurological outcome parameters when administered early in models of ischemic insult. Neurodegeneration models have examined cognitive parameters in some studies but not consistently across designs. Traumatic injury models have been another focus, with preclinical data examining neuroprotection. The research base is heterogeneous in quality, and the compound is characterised differently across regulatory jurisdictions.

Cerebrolysin is supplied for research purposes only. Not for human consumption. Handle in compliance with institutional biosafety guidelines.

Forskarnas förtroende

Varför forskare väljer CertaPeptides

Vem testar egentligen detta?

Utvalda partier verifieras oberoende av Janoshik Analytical (Tjeckien) och publiceras på Janoshiks offentliga portal. Övriga partier levereras med leverantörens partispecifikation. Se /coa för den publicerade väggen.

Visa COA:er →

Tänk om jag får fel parti?

Etiketten på varje vial bär en kod. Slå upp den på vår verifieringssida: där ser du vad CertaPeptides publicerar för koden och, för ett indraget parti, att partiet har dragits in och varför. Är ditt parti indraget, eller ger koden på din etikett ingen träff, skicka då den koden till oss via e-post.

Visa COA:er →

Varifrån skickas det?

Rumänien (EU). Vi är CERTALAB SRL, CUI 54169956, momsregistrerade. Sameday för Rumänien, GLS för de flesta EU-destinationer, TCE Worldwide för övriga gränsöverskridande EU- och icke-EU-marknader (Storbritannien, Schweiz). Leverans 1–15 arbetsdagar beroende på destination — exakt tidsfönster visas i kassan.

Fraktinformation →

Tänk om det uppstår ett problem?

Du har 14 dagars ångerrätt enligt OUG 34/2014 (rumänsk/EU-konsumentlagstiftning), med möjlighet till eskalering via ANPC och till alternativ tvistlösning (SAL). Kontakta oss på support@chinapeptideshop.com.

Returpolicy →

Produktinformation

Denna produkt är endast avsedd för vetenskaplig forskning och utveckling. Det är ett kemiskt ämne som inte får användas som läkemedel, medicin, aktiv substans eller ingrediens i någon produkt avsedd för konsumtion av människor eller djur. Forskare måste hantera denna förening i enlighet med sina institutionella riktlinjer för biosäkerhet. Använd endast i korrekt utrustade laboratoriemiljöer med lämplig personlig skyddsutrustning.

Vanliga frågor

Forskningsbibliotek

Relaterade forskningsartiklar

Visa alla

Frequently researched together

Combined Price €157.46

View All Products
Värva en forskare

Tipsa en forskarkollega

Ge 15% rabatt, tjäna 10% tillbaka på den första beställningen de gör.

Cerebrolysin 60mgResearch use only
Added to cart

Essential cookies keep your cart and account working. Optional content is disabled until you allow it.

Recently viewed products stay only in this browser for up to 30 days. Turning optional personalization off clears that history.

europa.eu/youreurope/reklamationsrätt

Customer support

Live chat is not connected yet. Please contact our support team by email.

support@chinapeptideshop.com